{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:11:50Z","timestamp":1779196310799,"version":"3.51.4"},"reference-count":7,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The addition of panitumumab to chemotherapy in wild-type metastatic colon cancer contributes to survival. While the skin related side effects of panitumumab are well known, we wanted to present a case where it was a possible cause of acute pancreatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Report<\/jats:title>\n                    <jats:p>The FOLFOX regimen was started in a 67-year-old patient with sigmoid colon cancer and multiple liver metastases. After 2 cycles, genetic tests were concluded and panitumumab 6\u2005mg\/kg was added to the treatment. The patient who presented with abdominal pain 2 days after the treatment was hospitalized with acute pancreaatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Management &amp; Outcome<\/jats:title>\n                    <jats:p>Abdominal tomography of the patient was compatible with acute pancreatitis. Oral intake was stopped, IV hydration was started. The patient, whose complaints regressed, was discharged on the 3rd day of hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Skin side effects related to panitumumab are observed quite frequently. Although panitumumab related gastrointestinal side effects have been reported, there is no data on acute pancreatitis. Panitumumab was added to the chemotherapy regimen he received, and it was thought that panitumumab might be the etiological factor in the case who developed pancreatitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552221073997","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T08:49:02Z","timestamp":1642409342000},"page":"1207-1208","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Panitumumab Associated Acute Pancreatitis"],"prefix":"10.1177","volume":"28","author":[{"given":"Huseyin Can","family":"Arbag","sequence":"first","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilmi Erdem","family":"Sumbul","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6356-9059","authenticated-orcid":false,"given":"Mahmut","family":"Buyuksimsek","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-7060","authenticated-orcid":false,"given":"Ali","family":"Ogul","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah Evren","family":"Yetisir","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8696-0525","authenticated-orcid":false,"given":"Tolga","family":"Koseci","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0295-6295","authenticated-orcid":false,"given":"Berna","family":"Bozkurt Duman","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mert","family":"Tohumcuoglu","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguzhan","family":"Kesen","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timucin","family":"Cil","sequence":"additional","affiliation":[{"name":"University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212474048"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.7116"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0187"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_3_2_6_2","first-page":"5113","article-title":"Oxaliplatin-induced pancreatitis: a case series","volume":"30","author":"Butt W","year":"2010","unstructured":"Butt W, Saadati H, Saif MW. Oxaliplatin-induced pancreatitis: a case series. Anticancer Res 2010; 30: 5113\u20135115.","journal-title":"Anticancer Res"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000486338"},{"key":"e_1_3_2_8_2","first-page":"2527","article-title":"The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation","volume":"8","author":"Ji Y","year":"2015","unstructured":"Ji Y, Han Z, Shao L, et al. The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation. Onco Targets Ther 2015; 8: 2527\u20132533.","journal-title":"Onco Targets Ther"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552221073997","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552221073997","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552221073997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:37:02Z","timestamp":1779194222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552221073997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1177\/10781552221073997"],"URL":"https:\/\/doi.org\/10.1177\/10781552221073997","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]}}}